A novel gelatin crosslinking method retards release of mulberry 1-deoxynojirimycin providing a prolonged hypoglycaemic effect
Mulberry 1-deoxynojirimycin (DNJ), a potent α-glycosidase inhibitor, has therapeutic potency in the suppression of postprandial blood glucose levels thereby possibly preventing diabetes mellitus. However, DNJ has a relatively short half-life in vivo (about 2 h). Therefore, several doses of mulberry...
Saved in:
Main Authors: | Chaluntorn Vichasilp, Kiyotaka Nakagawa, Phumon Sookwong, Ohki Higuchi, Fumiko Kimura, Teruo Miyazawa |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84861573909&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/51237 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
A novel gelatin crosslinking method retards release of mulberry 1-deoxynojirimycin providing a prolonged hypoglycaemic effect
by: Vichasilp C., et al.
Published: (2014) -
Tocotrienol fortification in eggs
by: Kiyotaka Nakagawa, et al.
Published: (2018) -
Tocotrienol fortification in eggs
by: Kiyotaka Nakagawa, et al.
Published: (2018) -
Mulberry-Derived 1-Deoxynojirimycin Prevents Type 2 Diabetes Mellitus Progression via Modulation of Retinol-Binding Protein 4 and Haptoglobin
by: Fongsodsri K.
Published: (2023) -
Sulphate-based flame-retardant for handmade mulberry paper
by: Naksata W., et al.
Published: (2014)